We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dual Drainage Cuts Pancreatic Stent Occlusion Rates

By HospiMedica International staff writers
Posted on 07 Nov 2013
Drainage with a combination of nasocystic drain and transmural stent outperformed stents alone in treating debris-laden pancreatic pseudocysts, according to a new study.

Researchers at Thomas Jefferson University Hospital (Philadelphia, PA, USA) conducted a retrospective study involving 87 patients with pancreatic pseudocysts to compare the clinical outcomes of endoscopic ultrasonography (EUS) guided pseudocyst drainage, both with and without a nasocystic drain for management of pancreatic pseudocysts with viscous solid debris-laden fluid. More...
In all, 63 patients with solid debris underwent drainage via nasocystic drains alongside stents, while 24 patients underwent drainage via transmural stents only. The primary outcomes were short- and long-term success of the procedures.

The results showed that patients whose pancreatic pseudocysts were drained via stent and nasocystic tubes had a significant threefold higher short-term success rate versus stents alone, as well as significantly lower rates of stent occlusion (13% versus 33%). Complete resolution of the debris-laden pseudocysts was more common among those treated with the tube and stent versus stent alone (79% versus 58%, respectively), though the difference was not significant. The study was published in the October 2013 issue of Gastrointestinal Endoscopy.

“Although the overall clinical success for effective pseudocyst decompression by endoscopic therapy is high, previous trials have demonstrated that the response depends on the type of pseudocyst,” said lead author Ali Siddiqui, MD, and colleagues. “Dual drainage with aggressive irrigation was shown to be an effective treatment for debris-laden viscous pancreatic cysts.”

Pseudocysts occur in 10%–20% of patients with acute pancreatitis, and in 20%–40% of those with chronic disease. These cysts are usually treated with surgery, but the procedure is associated with a 35% adverse event rate and 10% risk of mortality. Drainage of these cysts is indicated for intra-abdominal symptoms, cyst-related adverse events, or rapid increase in size, though drainage is not without its own problems.

Related Links:

Thomas Jefferson University Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.